Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,883
Total Claims
$1.2M
Drug Cost
437
Beneficiaries
$2,701
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
-97%
Opioid rate vs peers
0.1% vs 3.0% avg
+532%
Cost per patient vs peers
$2,701 vs $427 avg
+179%
Brand preference vs peers
14.6% vs 5.2% avg
Opioid Prescribing
0.1%
Opioid Rate
13
Opioid Claims
$136
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,165 claims · $842K
Generic: 12,652 claims · $335K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 521 | $149K |
| Valbenazine Tosylate | 31 | $103K |
| Insulin Glargine,hum.Rec.Anlog | 135 | $50K |
| Rivaroxaban | 131 | $37K |
| Linagliptin | 121 | $33K |
| Fluticasone/Vilanterol | 73 | $31K |
| Sitagliptin Phosphate | 105 | $26K |
| Rifaximin | 13 | $25K |
| Dulaglutide | 50 | $21K |
| Empagliflozin | 76 | $19K |
| Insulin Lispro | 51 | $15K |
| Divalproex Sodium | 189 | $14K |
| Clozapine | 206 | $13K |
| Fluticasone/Umeclidin/Vilanter | 18 | $12K |
| Atorvastatin Calcium | 977 | $12K |
Prescribing Profile
Patient Profile
76
Avg Age
60%
Female
2.82
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About